Cleared Traditional

K940472 - COXSACKIEVIRUS B5 MONOCLONAL ANTIBODY
(FDA 510(k) Clearance)

Sep 1995
Decision
583d
Days
Class 1
Risk

K940472 is an FDA 510(k) clearance for the COXSACKIEVIRUS B5 MONOCLONAL ANTIBODY. This device is classified as a Antisera, Fluorescent, Coxsackievirus A 1-24, B 1-6 (Class I - General Controls, product code GNM).

Submitted by Chemicon Intl., Inc. (Temecula, US). The FDA issued a Cleared decision on September 8, 1995, 583 days after receiving the submission on February 2, 1994.

This device falls under the Microbiology FDA review panel. Regulated under 21 CFR 866.3145.

Submission Details

510(k) Number K940472 FDA.gov
FDA Decision Cleared Substantially Equivalent - Traditional 510(k) (SESE)
Date Received February 02, 1994
Decision Date September 08, 1995
Days to Decision 583 days
Submission Type Traditional
Review Panel Microbiology (MI)
Summary Summary PDF

Device Classification

Product Code GNM — Antisera, Fluorescent, Coxsackievirus A 1-24, B 1-6
Device Class Class I - General Controls
CFR Regulation 21 CFR 866.3145

Similar Devices — GNM Antisera, Fluorescent, Coxsackievirus A 1-24, B 1-6

All 8
ENTEROVIRUS MONOCL ANTIBODY DET OF COXSACKIE A9 VIRUS
K936073 · Chemicon Intl., Inc. · Sep 1995
COXSACKIE A24 VIRUS MONOCLONAL ANTIBODY
K936089 · Chemicon Intl., Inc. · Sep 1995
COXSACKIEVIRUS B1 MONOCLONAL ANTIBODY
K936145 · Chemicon Intl., Inc. · Sep 1995
COXSACKIEVIRUS B3 MONOCLONAL ANTIBODY
K936251 · Light Diagnostics · Sep 1995
COXSACKIEVIRUS B@ MONOCLONAL ANTIBODY
K936252 · Light Diagnostics · Sep 1995
COXSACKIEVIRUS B4 MONOCLONAL ANTIBODY
K936253 · Light Diagnostics · Sep 1995